Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.
about
Rapid COJEC versus standard induction therapies for high-risk neuroblastomaShort duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group.Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma.Surgery combined with controlled-release doxorubicin silk films as a treatment strategy in an orthotopic neuroblastoma mouse model.Screening for neuroblastoma in the north of England.Expression of mdr-1/P-glycoprotein in human neuroblastoma.Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 studyWhere next with therapy in advanced neuroblastoma?Cisplatin therapy in infants: short and long-term morbidity.Schedule-dependent response of neuroblastoma cell lines to combinations of etoposide and cisplatin.Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation.Unchanged incidence and increased survival in children with neuroblastoma in Denmark 1981-2000: a population-based study.Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow.Serum neuron-specific enolase in children's cancer.Trends in childhood and adolescent cancer survival in Sweden 1960 through 1984.
P2860
Q24187922-0A0B0CC5-8651-46CF-A173-F4047804E8C1Q33409192-94A9811D-1259-4E72-8A10-28C605D6DD5CQ33840004-E25E9089-74D8-417A-95A8-80317F10097EQ34051924-71D0EB7F-5A5D-4589-9226-5795FE1BEA8DQ35824416-F8C83549-08D7-408A-BC57-52AB74FB0958Q35830452-296BD1B0-5CD7-4FEE-9C5F-6D95D4F58FDFQ35975829-942F2DD9-2FC4-4CB1-9705-6E78EE47E1CCQ35981380-C21F3B22-EB13-4999-BA9B-CC41BD8E0104Q36291203-F7196F2E-8A2F-46CC-B9C9-6E8E91F35466Q36643776-6AC177B2-DA2B-4DA6-85FF-DF8FB2C27EB9Q36762180-0E65A168-2C22-41B2-883E-86FD21722978Q37123462-9E85A034-48B2-4B84-BAA8-894533973792Q41143228-AE5B0968-0FB1-452D-9982-4440ACF65047Q41147783-893858E7-9EF3-4FB2-99A6-371C8580B5F6Q45285768-1F974877-E43C-484A-9F1B-8EE13290B9A6
P2860
Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh-hant
name
Advanced neuroblastoma: improv ...... equential cisplatin and VM-26.
@en
Advanced neuroblastoma: improved response rate using a multiagent regimen
@nl
type
label
Advanced neuroblastoma: improv ...... equential cisplatin and VM-26.
@en
Advanced neuroblastoma: improved response rate using a multiagent regimen
@nl
prefLabel
Advanced neuroblastoma: improv ...... equential cisplatin and VM-26.
@en
Advanced neuroblastoma: improved response rate using a multiagent regimen
@nl
P2093
P356
P1476
Advanced neuroblastoma: improv ...... equential cisplatin and VM-26.
@en
P2093
D W Rogers
E A Shafford
J Pritchard
P304
P356
10.1200/JCO.1984.2.7.742
P407
P577
1984-07-01T00:00:00Z